Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BIA 6-512 PK interaction with Levodopa in healthy volunteers
NCT03091543Phase 1Completed
- Sponsor
- BIAL
- Start
- May 2004
- Primary completion
- Jul 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of resveratrol in Parkinson's disease (PD) (5 arms), sponsored by BIAL. Primary endpoints: Maximum observed plasma drug concentration, Time of occurrence of Cmax and 3 more. Started May 2004; status: completed.
02
Drugs
resveratrol
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT03091543.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03091543.